Çobanoğlu, Fatma NazanErsöz, Deniz DoğruÇakır, ErkanEyüboğlu, Tuğba ŞişmanlarPekcan, SevgiCinel, GüzinYalçın, EbruKiper, NuralŞen, VelatŞen, Hadice SelimogluErcan, ÖmurKeskin, ÖzlemEltan, Sevgi BilgicAl Shadfan, Lina MuhammedYazan, HakanAltintas, Derya UfukSasihuseyinoglu, SenaySapan, NihatÇekiç, ŞükrüCokugras, HalukAtabek, Ayse AyzitGursoy, Tugba RamasliAslan, Ayse TanaBingol, AysenBasaran, Abdurrahman ErdemÖzdemir, AliKose, MehmetHangul, MelihEmiralioglu, NagehanTugcu, GokcenYuksel, HasanYilmaz, ÖzgeOrhan, FazilAydin, Zeynep Gokce GayretliTopal, ErdemTamay, ZeynepSüleyman, AyşeCan, DemetBal, Cem MuratCaltepe, GönülÖzçelik, Ugur2024-12-032024-12-032019-09-280903-1936https://doi.org/10.1183/13993003.congress-2019.PA4518https://publications.ersnet.org/content/erj/54/suppl63/pa4518https://hdl.handle.net/11452/48824Bu çalışma, Eylül 28-Ekim 02, 2019 tarihlerinde Madrid[İspanya]’da düzenlenen International Congress of the European-Respiratory-Society (ERS) Kongresi‘nde bildiri olarak sunulmuştur.eninfo:eu-repo/semantics/closedAccessRespiratory systemCystic fibrosis patients eligible for modulator drugs: Data from cystic fibrosis registry of TurkeyMeeting Abstract00050737240603054Supplement 6310.1183/13993003.congress-2019.PA4518